In the tumor microenvironment, myeloid cells expressed much higher level of PD-L1 than tumor and stromal (CD45-) cells, and mProIFNa4-Fc treatment increased PD-L1 expression on both CD45– cells and myeloid cells (Fig. 5k). The gene discussed is CD274; the disease is neoplasm.